AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 5th, 2016 • Celator Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment to the Employment Agreement is dated as of April 1, 2016 between Celator Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Scott T. Jackson (the “Executive”).
Celator Pharmaceuticals, Inc. 200 PrincetonSouth Corporate Center Suite 180 Ewing, NJ 08628 Tel: 609.243.0123 Fax: 609.243.0202 www.celatorpharma.comCelator Pharmaceuticals Inc • April 5th, 2016 • Pharmaceutical preparations
Reference is made to the Amended and Restated Executive Employment Agreement dated as of December 19, 2002 (the “Employment Agreement”) between you and Celator Pharmaceuticals Corp. (the “Corporation”), as successor in interest to Celator Technologies Inc., pursuant to which you were employed by the Corporation as President and Head of Research effective December 19, 2002, and you are now serving as President and Chief Scientific Officer.
Celator Pharmaceuticals, Inc. 200 PrincetonSouth Corporate Center Suite 180 Ewing, NJ 08628 Tel: 609.243.0123 Fax: 609.243.0202 www.celatorpharma.comCovenants Agreement • April 5th, 2016 • Celator Pharmaceuticals Inc • Pharmaceutical preparations
Reference is made to the Letter and Restrictive Covenants Agreement dated as of December 7, 2012, as amended, (the “Letter Agreement”) between you and Celator Pharmaceuticals, Inc. (the “Company”), pursuant to which you were employed by the Company as Vice-President and Chief Financial Officer effective December 17, 2012.
